Day: August 5, 2025

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

Written by Customer Service on August 5, 2025. Posted in Public Companies.

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced it has signed a contract with Asklepion Pharmaceuticals to deploy its NetraAI platform to analyze results from its pivotal Phase III pediatric clinical trial. The agreement covers the application of NetraAI’s advanced AI technology to analyze patient data from Asklepion’s CIT-003-01 study, which evaluated the efficacy of intravenous L-citrulline for preventing acute lung injury in children undergoing cardiopulmonary bypass surgery for congenital heart defects. Asklepion is deeply focused on translating science into meaningful therapies for children. By incorporating NetraMark’s AI analytics into their...

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Written by Customer Service on August 5, 2025. Posted in Public Companies.

Supported by the recent CMS decision to increase the reimbursement rate, which facilitates broader use of the therapy in outpatient settings MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming fluid management, today announced that the first patients have been successfully treated with Aquadex® ultrafiltration therapy in a hospital-based outpatient setting. This milestone reflects a major advancement in the company’s mission to improve access to fluid management and support better care across the continuum. The treatments were performed at a leading healthcare institution in the southeastern United States using the same Aquadex SmartFlow® system and clinical protocols trusted in inpatient environments. By enabling therapy in a hospital-based outpatient...

ZenaTech Closes a Seventh Drone as a Service (DaaS) Acquisition in North Carolina Expanding its Southeast Region and Government Opportunities

Written by Customer Service on August 5, 2025. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-powered drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announced the closing of its seventh Drone as a Service acquisition. Morgan Surveying, Inc. is a Greensboro, North Carolina-based land surveying firm with an established reputation for serving customers in Guilford County and surrounding areas for over 30 years. This marks the first completed acquisition in North Carolina, expanding the DaaS business presence in the Southeast region along with five recent Florida-based acquisitions. It also enhances the company’s ability to sell to both government and commercial customers. “By bringing Morgan Surveying...

Tecan schedules conference call on August 12th to discuss half year 2025 financial results

Written by Customer Service on August 5, 2025. Posted in Public Companies.

Männedorf, Switzerland, August 5, 2025 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2025 on Tuesday, August 12th, 2025 at 08:30 CEST. The results will be published on August 12th, 2025 at 6:00 CEST. The conference call will be audio-webcast with synchronized presentation slides. The webcast and a replay of the webcast will be made available in the “Investor Relations” section of Tecan’s website www.tecan.com. Interested parties can also listen to the conference call by phone. The dial-in numbers for the call are as follows:Participants from Europe: +41 (0) 58 310 50 00 or +44 (0) 207 107 0613 (UK) Participants from the U.S.: +1 (1) 631 570 56 13Participants should if possible dial in 15 minutes before the start of the event. On August...

Magnite and REMAX Team Up to Power Commerce Media Expansion Across Onsite and Offsite Channels

Written by Customer Service on August 5, 2025. Posted in Public Companies.

Magnite will work with the real estate leader to extend its high-value audiences offsite and unlock new routes for brands to connect with high-intent home buyers NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced that REMAX, LLC, one of the world’s leading franchisors of real estate brokerage services, has selected Magnite as its partner to accelerate the growth of its commerce media business. REMAX will work with Magnite to monetize its onsite digital inventory and activate its first-party home buyer data offsite via curated audience packages, creating new opportunities for brands to reach high-intent home buyers. REMAX is the first real estate franchisor brand to launch a commerce media network, revolutionizing the way real estate and advertising...

BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

Written by Customer Service on August 5, 2025. Posted in Public Companies.

HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication, will host its second quarter 2025 investor call on Wednesday, August 13th at 10 a.m. ET. Results will be released before the stock market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session.Call Details Date / Time:Call Dial In #:Live Webcast / Replay:Audio Replay: Wednesday, August 13th at 10 a.m. ET1-877-418-5460 U.S. or 1-412-717-9594 Int’lWebcast & Replay Link – Available for 3 months.1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 8281392About BIO-key International,...

Rackspace Technology Launches Cloud Management Platform with New Capabilities for Hybrid Environments

Written by Customer Service on August 5, 2025. Posted in Public Companies.

Next-gen upgrades empower organizations to streamline workload operations and optimize their entire cloud infrastructure from a single AI-enabled platform SAN ANTONIO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the launch of the Rackspace Cloud Management Platform, which includes next-gen upgrades to the Rackspace Managed Cloud (“RMC”) offering. The platform provides customers with a single robust framework that leverages best-in-class AI-enabled tools, empowering organizations to streamline workload operations, accelerate digital transformation, and more efficiently manage modern hybrid and multicloud environments. In addition to providing customers with full-stack observability, intelligent application optimization, and adherence...

StoneX Completes Acquisition of The Benchmark Company to Expand Investment Banking Capabilities

Written by Customer Service on August 5, 2025. Posted in Mergers And Acquisitions.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX), a global financial services firm connecting clients to the markets across asset classes and geographies, today announced the successful completion of its acquisition of The Benchmark Company, LLC (“Benchmark”), a leading provider of investment banking, equity research, and institutional sales and trading services. The transaction, originally announced on March 11, 2025, adds a complementary suite of capabilities to StoneX’s existing offerings, enhancing its capital markets offering and establishing a deeper presence in Investment Banking and Equity Research. Strategic Fit and Integration Plans Benchmark brings a seasoned investment banking team, as well as professionals across institutional sales, trading, and equity research. The firm is recognized for...

Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Written by Customer Service on August 5, 2025. Posted in Earnings Releases And Operating Results.

NXP900 becomes the lead drug candidate after successfully completing the Phase 1a dose escalation study in patients with advanced solid tumors and a drug-drug interaction study in healthy volunteers; initiation of Phase 1b program is imminent Strengthened cash position following a July At-The-Market (ATM) shares acquisition by a healthcare-dedicated institutional investor; June 30, 2025 proforma cash position of approximately $39 millionFORT LEE, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the second quarter 2025 and provided...

Hillman Reports Second Quarter 2025 Results

Written by Customer Service on August 5, 2025. Posted in Earnings Releases And Operating Results.

Raises mid-point of 2025 Net Sales and Adj. EBITDA guidance Board approves $100 million Share Repurchase Program CINCINNATI, Aug. 05, 2025 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, reported financial results for the thirteen and twenty-six weeks ended June 28, 2025. Second Quarter 2025 Highlights (Thirteen weeks ended June 28, 2025)Net sales increased 6.2% to $402.8 million compared to $379.4 million in the prior year quarter Net income totaled $15.8 million, or $0.08 per diluted share, compared to $12.5 million, or $0.06 per diluted share, in the prior year quarter Adjusted diluted EPS1 totaled $0.17 per diluted share compared to $0.16 per diluted share in the prior year quarter Adjusted EBITDA1 increased to $75.2...

Day: August 5, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals